Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

67 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Studies of human tumors by MRS: a review.
Negendank W. Negendank W. NMR Biomed. 1992 Sep-Oct;5(5):303-24. doi: 10.1002/nbm.1940050518. NMR Biomed. 1992. PMID: 1333263 Review.
Phosphomonoester concentrations differ between chronic lymphocytic leukemia cells and normal human lymphocytes.
Franks SE, Smith MR, Arias-Mendoza F, Shaller C, Padavic-Shaller K, Kappler F, Zhang Y, Negendank WG, Brown TR. Franks SE, et al. Among authors: negendank wg. Leuk Res. 2002 Oct;26(10):919-26. doi: 10.1016/s0145-2126(02)00035-8. Leuk Res. 2002. PMID: 12163053
Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver.
Murphy-Boesch J, Li CW, He L, Padavic-Shaller KA, Negendank W, Brown TR. Murphy-Boesch J, et al. Among authors: negendank w. Magn Reson Med. 1997 Mar;37(3):321-6. doi: 10.1002/mrm.1910370302. Magn Reson Med. 1997. PMID: 9055218
Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies.
Negendank W, Li CW, Padavic-Shaller K, Murphy-Boesch J, Brown TR. Negendank W, et al. Anticancer Res. 1996 May-Jun;16(3B):1539-44. Anticancer Res. 1996. PMID: 8694523 Review.
Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial.
Negendank W, Sauter R. Negendank W, et al. Anticancer Res. 1996 May-Jun;16(3B):1533-8. Anticancer Res. 1996. PMID: 8694522 Review.
Magnetic resonance imaging in patients with bone marrow disorders.
Negendank W, Soulen RL. Negendank W, et al. Leuk Lymphoma. 1993 Jul;10(4-5):287-98. doi: 10.3109/10428199309148551. Leuk Lymphoma. 1993. PMID: 8220127 Review.
Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer.
Freedman GM, Negendank WG, Hudes GR, Shaer AH, Hanks GE. Freedman GM, et al. Among authors: negendank wg. Urology. 1999 Jul;54(1):118-23. doi: 10.1016/s0090-4295(99)00090-4. Urology. 1999. PMID: 10414737
Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.
Li CW, Negendank WG, Padavic-Shaller KA, O'Dwyer PJ, Murphy-Boesch J, Brown TR. Li CW, et al. Among authors: negendank wg. Clin Cancer Res. 1996 Feb;2(2):339-45. Clin Cancer Res. 1996. PMID: 9816177 Free article.
Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging.
Li CW, Negendank WG, Murphy-Boesch J, Padavic-Shaller K, Brown TR. Li CW, et al. Among authors: negendank wg. NMR Biomed. 1996 Jun;9(4):141-55. doi: 10.1002/(SICI)1099-1492(199606)9:4<141::AID-NBM403>3.0.CO;2-P. NMR Biomed. 1996. PMID: 9015801
Simultaneous 3D NMR spectroscopy of proton-decoupled fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy.
Gonen O, Murphy-Boesch J, Li CW, Padavic-Shaller K, Negendank WG, Brown TR. Gonen O, et al. Among authors: negendank wg. Magn Reson Med. 1997 Feb;37(2):164-9. doi: 10.1002/mrm.1910370203. Magn Reson Med. 1997. PMID: 9001138
67 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page